Viewing Study NCT00456794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-05-24 @ 8:58 AM
Study NCT ID: NCT00456794
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2007-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Sponsor: Kyowa Kirin, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 6002-US-006
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators